BIOMAT Database Logo BIOMAT Database Logo

Clonal evolution in a transforming 5q- syndrome. 1994

D Kandioler, and O Krieger, and H Nowotny, and D Lutz

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D002895 Chromosomes, Human, Pair 5 One of the two pairs of human chromosomes in the group B class (CHROMOSOMES, HUMAN, 4-5). Chromosome 5
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000753 Anemia, Refractory A severe sometimes chronic anemia, usually macrocytic in type, that does not respond to ordinary antianemic therapy. Refractory Anemia,Anemias, Refractory,Refractory Anemias
D000754 Anemia, Refractory, with Excess of Blasts Chronic refractory anemia with granulocytopenia, and/or thrombocytopenia. Myeloblasts and progranulocytes constitute 5 to 40 percent of the nucleated marrow cells. Leukemia, Smoldering,RAEB,RAEM,Refractory Anemia with Excess of Blasts,Leukemia, Smouldering,Leukemias, Smoldering,Smoldering Leukemia,Smoldering Leukemias,Smouldering Leukemia

Related Publications

D Kandioler, and O Krieger, and H Nowotny, and D Lutz
Clonal evolution in primary 5q-syndrome.
July 1992, Cancer,
D Kandioler, and O Krieger, and H Nowotny, and D Lutz
Unusual clonal evolution involving 5q in a case of myelodysplastic syndrome with deletion 5q 31 treated with lenalidomide.
February 2008, Haematologica,
D Kandioler, and O Krieger, and H Nowotny, and D Lutz
Cytogenetic evidence of clonal evolution in 5q- anemia.
July 1977, Biomedicine / [publiee pour l'A.A.I.C.I.G.],
D Kandioler, and O Krieger, and H Nowotny, and D Lutz
Routes of Clonal Evolution into Complex Karyotypes in Myelodysplastic Syndrome Patients with 5q Deletion.
October 2018, International journal of molecular sciences,
D Kandioler, and O Krieger, and H Nowotny, and D Lutz
Clonal monosomy 7 and 5q--in a child with myelodysplastic syndrome.
September 2000, Pediatric hematology and oncology,
D Kandioler, and O Krieger, and H Nowotny, and D Lutz
Treatment-emergent mutations in myelodysplastic syndrome with del(5q) - lenalidomide related or disease-intrinsic clonal evolution?
March 2024, Blood cancer journal,
D Kandioler, and O Krieger, and H Nowotny, and D Lutz
Myelodysplastic syndrome with isolated 5q deletion (5q- syndrome). A clonal stem cell disorder characterized by defective ribosome biogenesis.
July 2008, Haematologica,
D Kandioler, and O Krieger, and H Nowotny, and D Lutz
Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomide.
February 2012, Leukemia,
D Kandioler, and O Krieger, and H Nowotny, and D Lutz
Cytogenetic evidence of clonal evolution in a case of hemopoietic dysplasia with a 5q- chromosome.
September 1983, Cancer genetics and cytogenetics,
D Kandioler, and O Krieger, and H Nowotny, and D Lutz
Clonal evolution in myelodysplastic syndromes with isolated del(5q): the importance of genetic monitoring.
February 2011, Haematologica,
Copied contents to your clipboard!